Leap Therapeutics (LPTX) Short Interest Ratio & Short Volume $0.34 +0.02 (+4.82%) Closing price 04:00 PM EasternExtended Trading$0.34 0.00 (-0.59%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Leap Therapeutics Short Interest DataLeap Therapeutics (LPTX) has a short interest of 2.05 million shares, representing 6.67% of the float (the number of shares available for trading by the public). This marks a -28.07% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.6, indicating that it would take 1.6 days of the average trading volume of 1.68 million shares to cover all short positions.Current Short Interest2,050,000 sharesPrevious Short Interest2,850,000 sharesChange Vs. Previous Month-28.07%Dollar Volume Sold Short$686.14 thousandShort Interest Ratio1.6 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares41,440,000 sharesFloat Size30,740,000 sharesShort Percent of Float6.67%Today's Trading Volume400,577 sharesAverage Trading Volume1,684,019 sharesToday's Volume Vs. Average24% Short Selling Leap Therapeutics? Sign up to receive the latest short interest report for Leap Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartLPTX Short Interest Over TimeLPTX Days to Cover Over TimeLPTX Percentage of Float Shorted Over Time Leap Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/20252,050,000 shares $686.14 thousand -28.1%6.7%1.6 $0.33 6/30/20252,850,000 shares $846.17 thousand +79.3%9.3%2.3 $0.30 6/15/20251,590,000 shares $651.74 thousand +3.3%5.2%0.5 $0.41 5/31/20251,540,000 shares $571.34 thousand -18.5%5.0%0.7 $0.37 5/15/20251,890,000 shares $778.68 thousand -14.5%6.2%0.9 $0.41 4/30/20252,210,000 shares $924.00 thousand -36.1%7.2%1 $0.42 4/15/20253,460,000 shares $1.30 million -9.2%11.3%1.4 $0.37 3/31/20253,810,000 shares $1.16 million +147.4%12.5%1.5 $0.31 3/15/20251,540,000 shares $616.15 thousand -18.5%5.4%2.1 $0.40 2/28/20251,890,000 shares $875.64 thousand -11.3%6.6%2.5 $0.46 Get the Latest News and Ratings for LPTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Leap Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/20252,130,000 shares $1.07 million -33.6%7.5%2.8 $0.50 1/31/20253,210,000 shares $1.80 million +30.5%11.2%4.3 $0.56 1/15/20252,460,000 shares $8.00 million +12.3%8.6%5.7 $3.25 12/31/20242,190,000 shares $6.31 million +2.3%7.7%5.8 $2.88 12/15/20242,140,000 shares $6.31 million +50.7%7.5%6.1 $2.95 11/30/20241,420,000 shares $4.23 million No Change5.0%4.4 $2.98 11/15/20241,420,000 shares $3.89 million +40.6%5.0%5.3 $2.74 10/31/20241,010,000 shares $3.78 million +39.6%3.5%4.3 $3.74 10/15/2024723,500 shares $1.66 million -19.5%2.4%4.9 $2.29 9/30/2024899,100 shares $2.31 million -11.0%3.0%7.8 $2.57 9/15/20241,010,000 shares $2.77 million -2.9%3.4%8.4 $2.74 8/31/20241,040,000 shares $3.02 million -15.5%3.5%8.9 $2.90 8/15/20241,230,000 shares $3.03 million +17.1%4.1%9.2 $2.46 7/31/20241,050,000 shares $2.25 million -7.1%3.5%7.2 $2.14 7/15/20241,130,000 shares $2.46 million +6.6%3.8%6.8 $2.18 6/30/20241,060,000 shares $2.08 million -14.5%3.6%3.6 $1.96 6/15/20241,240,000 shares $2.62 million -3.1%4.2%4.2 $2.11 5/31/20241,280,000 shares $3.11 million -5.2%5.0%4.3 $2.43 5/15/20241,350,000 shares $3.78 million -0.7%5.3%4.4 $2.80 4/30/20241,360,000 shares $4.22 million -6.2%5.6%4.5 $3.10 4/15/20241,450,000 shares $4.35 million +27.2%6.2%4.5 $3.00 3/31/20241,140,000 shares $3.03 million +0.9%4.9%4.7 $2.66 3/15/20241,130,000 shares $2.50 million -3.4%4.8%4.4 $2.21 2/29/20241,170,000 shares $3.26 million +4.5%5.0%4.4 $2.79 2/15/20241,120,000 shares $3.66 million +74.8%4.8%4 $3.27 1/31/2024640,800 shares $1.92 million +7.3%2.7%2.2 $3.00 1/15/2024597,400 shares $2.10 million +5.3%2.5%2.3 $3.51 12/31/2023567,300 shares $2.35 million +2.9%2.4%2.4 $4.15 12/15/2023551,200 shares $1.67 million -2.2%2.4%1.8 $3.03 11/30/2023563,600 shares $1.27 million -29.4%2.4%2 $2.25These 5 Stocks Are Thriving Under Trump’s Presidency (Ad)Trump is back in the White House—and new market winners are already emerging. A free report reveals 5 stocks poised to benefit from early policy shifts, sector momentum, and the evolving 2025 economy.Download your free report: 5 Best Stocks for Trump’s America 11/15/2023798,100 shares $1.28 million +7.2%3.4%2.9 $1.60 10/31/2023744,200 shares $1.09 million +24.6%3.2%3.1 $1.47 10/15/2023597,500 shares $908.20 thousand -15.1%2.5%2 $1.52 9/30/2023703,400 shares $970.69 thousand +2.7%3.0%2.1 $1.38 9/15/2023684,800 shares $1.08 million +1.9%2.9%2.7 $1.57 8/31/2023671,800 shares $1.50 million -3.2%3.2%2.6 $2.23 8/15/2023694,300 shares $1.76 million -5.3%3.3%2.7 $2.54 7/31/2023732,800 shares $2.01 million -36.3%7.5%2.9 $2.74 7/15/20231,150,000 shares $3.62 million +3.6%12.0%6.4 $3.15 6/30/20231,110,000 shares $3.47 million +6.7%11.6%7.9 $3.13 6/15/20231,040,000 shares $6.29 million -89.8%10.8%8.6 $6.05 5/31/202310,230,000 shares $9.10 million -11.2%N/A10.5 $0.89 5/15/202311,520,000 shares $5.18 million +0.1%N/A14.7 $0.45 4/30/202311,510,000 shares $4.50 million No ChangeN/A19.4 $0.39 4/15/202311,510,000 shares $4.52 million +1.1%N/A16.3 $0.39 3/31/202311,390,000 shares $3.87 million +20.0%N/A15.8 $0.34 3/15/20239,490,000 shares $3.92 million +5.8%N/A12.2 $0.41 2/28/20238,970,000 shares $5.11 million +45.2%N/A12.3 $0.57 2/15/20236,180,000 shares $3.72 million +22.1%N/A8.5 $0.60 1/31/20235,060,000 shares $3.36 million +15.0%N/A6.2 $0.67 1/15/20234,400,000 shares $2.56 million +57.1%N/A5.5 $0.58 12/30/20222,800,000 shares $1.26 million +27.3%N/A4.6 $0.45 12/15/20222,200,000 shares $1.10 million -1.4%N/A3.9 $0.50 11/30/20222,230,000 shares $1.35 million -6.3%N/A3.6 $0.60 11/15/20222,380,000 shares $1.67 million -32.6%N/A3.5 $0.70 10/31/20223,530,000 shares $3.00 million +10.3%N/A5.1 $0.85 10/15/20223,200,000 shares $2.82 million +10.7%N/A5.3 $0.88 9/30/20222,890,000 shares $2.54 million +10.7%N/A4.7 $0.88 9/15/20222,610,000 shares $3.08 million No ChangeN/A3.9 $1.18 8/31/20222,610,000 shares $3.71 million +6.5%N/A4.1 $1.42 8/15/20222,450,000 shares $3.50 million -70.6%N/A3.9 $1.43 7/31/20228,340,000 shares $8.67 million -37.4%N/A12.1 $1.04 7/15/202213,320,000 shares $14.52 million -1.4%N/A18.1 $1.09 6/30/202213,510,000 shares $15.54 million -1.0%N/A17 $1.15 6/15/202213,650,000 shares $13.92 million -1.1%N/A17.2 $1.02 5/31/202213,800,000 shares $14.90 million -1.9%N/A17.8 $1.08 5/15/202214,070,000 shares $18.43 million No ChangeN/A18.7 $1.31 4/30/202214,070,000 shares $18.15 million +1.2%N/A17.3 $1.29 4/15/202213,910,000 shares $22.12 million -0.1%N/A13.6 $1.59 3/31/202213,930,000 shares $24.38 million +0.4%N/A10.7 $1.75 3/15/202213,880,000 shares $23.32 million No ChangeN/A8.8 $1.68 2/28/202213,880,000 shares $27.62 million -2.3%N/A8 $1.99 2/15/202214,200,000 shares $34.08 million +4.1%N/A7.4 $2.40 1/31/202213,640,000 shares $26.46 million -8.1%N/A7 $1.94 1/15/202214,840,000 shares $42.15 million +12.9%N/A7.7 $2.84 12/31/202113,150,000 shares $42.61 million +12.9%N/A6.7 $3.24 12/15/202111,650,000 shares $29.13 million +12.8%N/A4.3 $2.50 11/30/202110,330,000 shares $26.96 million +3.8%N/A1.6 $2.61 11/15/20219,950,000 shares $23.88 million -5.8%N/A1.6 $2.40 10/29/202110,560,000 shares $29.46 million -1.5%N/A1.7 $2.79These 5 Stocks Are Thriving Under Trump’s Presidency (Ad)Trump is back in the White House—and new market winners are already emerging. A free report reveals 5 stocks poised to benefit from early policy shifts, sector momentum, and the evolving 2025 economy.Download your free report: 5 Best Stocks for Trump’s America 10/15/202110,720,000 shares $33.77 million -6.1%N/A1.8 $3.15 9/30/202111,410,000 shares $45.75 million +152.4%N/A2.1 $4.01 9/15/20214,520,000 shares $8.72 million +99.1%9.8%1 $1.93 8/31/20212,270,000 shares $3.90 million +33.5%4.9%4 $1.72 8/13/20211,700,000 shares $2.86 million +39.3%3.7%4.3 $1.68 7/30/20211,220,000 shares $1.73 million -0.8%2.7%3.4 $1.42 7/15/20211,230,000 shares $1.72 million -2.4%2.7%4.1 $1.40 6/30/20211,260,000 shares $2.07 million +2.4%2.8%3.6 $1.64 6/15/20211,230,000 shares $2.19 million +8.9%2.7%3.1 $1.78 5/28/20211,130,000 shares $1.83 million -4.2%2.5%2 $1.62 5/14/20211,180,000 shares $1.75 million -21.9%N/A2 $1.48 4/30/20211,510,000 shares $2.57 million +2.7%N/A2 $1.70 4/15/20211,470,000 shares $2.56 million -7.6%N/A1.7 $1.74 3/31/20211,590,000 shares $2.93 million +12.0%N/A1.8 $1.84 3/15/20211,420,000 shares $3.39 million +16.4%N/A1.3 $2.39 2/26/20211,220,000 shares $3.00 million +15.1%N/A1.2 $2.46 2/12/20211,060,000 shares $2.92 million +13.7%N/A1.1 $2.75 1/29/2021932,600 shares $2.15 million -23.6%N/A0.9 $2.31 1/15/20211,220,000 shares $2.71 million +13.0%N/A1.3 $2.22 12/31/20201,080,000 shares $2.39 million +38.8%N/A1.2 $2.21 12/15/2020778,400 shares $1.43 million +24.3%N/A0.9 $1.84 11/30/2020626,300 shares $995.82 thousand +8.2%N/A1 $1.59 11/15/2020579,000 shares $926.40 thousand +3.0%N/A1 $1.60 10/30/2020562,200 shares $1.11 million +4.6%N/A1.1 $1.98 10/15/2020537,700 shares $1.15 million -34.6%N/A1.1 $2.13 9/30/2020821,800 shares $1.63 million -5.3%N/A1.2 $1.98 9/15/2020868,100 shares $1.66 million +6.3%N/A1.1 $1.91 8/31/2020816,400 shares $1.42 million -10.2%N/A0.9 $1.74 8/14/2020908,900 shares $1.73 million -13.4%N/A1 $1.90 LPTX Short Interest - Frequently Asked Questions What is Leap Therapeutics' current short interest? Short interest is the volume of Leap Therapeutics shares that have been sold short but have not yet been closed out or covered. As of July 15th, investors have sold 2,050,000 shares of LPTX short. 6.67% of Leap Therapeutics' shares are currently sold short. Learn More on Leap Therapeutics' current short interest. What is a good short interest ratio for Leap Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LPTX shares currently have a short interest ratio of 2.0. Learn More on Leap Therapeutics's short interest ratio. Which institutional investors are shorting Leap Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Leap Therapeutics: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Leap Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.67% of Leap Therapeutics' floating shares are currently sold short. Is Leap Therapeutics' short interest increasing or decreasing? Leap Therapeutics saw a decrease in short interest in the month of July. As of July 15th, there was short interest totaling 2,050,000 shares, a decrease of 28.1% from the previous total of 2,850,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Leap Therapeutics' float size? Leap Therapeutics currently has issued a total of 41,440,000 shares. Some of Leap Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Leap Therapeutics currently has a public float of 30,740,000 shares. How does Leap Therapeutics' short interest compare to its competitors? 6.67% of Leap Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Leap Therapeutics: Precision BioSciences, Inc. (13.33%), PDS Biotechnology Corporation (5.34%), CEL-SCI Co. (22.85%), Annovis Bio, Inc. (12.62%), Adverum Biotechnologies, Inc. (7.45%), KALA BIO, Inc. (6.11%), Prelude Therapeutics Incorporated (2.14%), ABVC BioPharma, Inc. (3.64%), vTv Therapeutics Inc. (0.98%), Century Therapeutics, Inc. (3.42%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Leap Therapeutics stock? Short selling LPTX is an investing strategy that aims to generate trading profit from Leap Therapeutics as its price is falling. LPTX shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Leap Therapeutics? A short squeeze for Leap Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LPTX, which in turn drives the price of the stock up even further. How often is Leap Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LPTX, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies Precision BioSciences Short Interest PDS Biotechnology Short Interest CEL-SCI Short Interest Annovis Bio Short Interest Adverum Biotechnologies Short Interest KALA BIO Short Interest Prelude Therapeutics Short Interest ABVC BioPharma Short Interest vTv Therapeutics Short Interest Century Therapeutics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LPTX) was last updated on 8/13/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Leap Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Leap Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.